Company:  ARIAD PHARMACEUTICALS INC (ARIA)
Form Type:  8-K
Filing Date:  8/2/2012 
CIK:  0000884731 
Address:  26 LANDSDOWNE ST 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  (617) 494-0400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.74  
Change: 
0.15 (2.68%)  
Trade Time: 
11:31 AM EST  
Market Cap: 
$1.07B
Description of Business
The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and other factors including the risk factors set forth in Part I, Item 1A of this annual report. Unless the content requires otherwise, references to �ARIAD,� �company,� �we,� �our,� and �us,� in this annual report refer to ARIAD Pharmaceuticals, Inc. and our subsidiaries. Overview ARIAD is a global oncology company whose vision is to transform the lives of cancer patients with breakthrough medicines. Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest unmet medical need � aggressive cancers where current therapies are inadequate.
Register for a Free Trial and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      ITEM 2.02 Results of Operations and Financial Condition.
    SECTION 7 REGULATION FD
      ITEM 7.01 Regulation FD Disclosure.
    SECTION 8 OTHER EVENTS
      ITEM 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      ITEM 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET
    CASH FLOW